The COVID Treatment QuickStart Consortium

Representatives from Ministry of Health-Zambia, University teaching Hospital, Clinton Health Access Initiative and Duke University during the hospital visit
Regions
  • Africa
  • Asia-Pacific
  • East Asia
Countries
  • Ghana
  • Kenya
  • Laos
  • Malawi
  • Nigeria
  • Rwanda
  • South Africa
  • Uganda
  • Zambia
  • Zimbabwe
Current status
Open
More Information
Representatives from Ministry of Health-Zambia, University teaching Hospital, Clinton Health Access Initiative and Duke University during the hospital visit

The COVID Treatment QuickStart Consortium Scaling Access to New COVID-19 Oral Antiviral Therapies in LMICs

Project overview

The COVID Treatment QuickStart Consortium is a catalytic, multi-partner led initiative to support governments in Ghana, Kenya, Laos, Malawi, Nigeria, Rwanda, South Africa, Uganda, Zambia, and Zimbabwe, to introduce and scale up access to new and effective COVID-19 oral antiviral therapies in high-risk populations. Duke GHIC supports the coordination of the consortium, engages with key stakeholders, and conducts critical research and dissemination of insights on the implementation of QuickStart test and treat programs.

Topics
  • Access to Medicine / Health
  • Financing, Health Policy, Regulation, Universal Health Care
  • Health Systems, Primary Care
  • Pandemic Prevention, Preparedness, and Response / COVID-19
Capabilities
  • Capacity Building and Education
  • Convening
  • Evidence generation through research
Funders/Sponsors
Open Society Foundations; Pfizer; the Conrad N. Hilton Foundation
Partners
Duke University; Americares; Clinton Health Access Initiative (CHAI); COVID Collaborative
Related resources
Related news